Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-01

Clinical Trial Update: The T2D Profile - Studies of the Omics Profile in Type 2 Diabetes

View source ↗

Summary

Göteborg University reports the completion of studies examining omics profiling in individuals with Diabetes Mellitus, Type 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Göteborg University | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED